Home » Products » Other Category » 100 mg Bevacizumab Concentrate for Solution for Intravenous Infusion

100 mg Bevacizumab Concentrate for Solution for Intravenous Infusion

100 mg Bevacizumab Concentrate for Solution for Intravenous Infusion
100 mg Bevacizumab Concentrate for Solution for Intravenous Infusion
Send Inquiry
Product Code : Bevacizumab
Product Description
100 mg Bevacizumab Concentrate for Solution for Intravenous Infusion is indicated for age-related macular degeneration and treatment of certain types of cancers including renal cell carcinoma & glioblastoma. It is administered via intravenous route with 100% bioavailability and average elimination half life of about 20 days. Bevacizumab is a type of recombinant humanized monoclonal antibody which works by inhibiting vascular endothelial growth factor A thus angiogenesis is blocked. 100 mg Bevacizumab Concentrate for Solution for Intravenous Infusion is highly effective in nature & assures targeted action and can be availed at reasonable rates in large quantities as per demand.

NEXT GEN BIOTECH
X


Back to top
NEXT GEN BIOTECH All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.